标题
Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 87, Issue 4, Pages 459-464
出版商
Springer Nature
发表日期
2010-01-14
DOI
10.1038/clpt.2009.223
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy
- (2009) V. Perez-Andreu et al. BLOOD
- Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
- (2009) N. A. Limdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
- (2009) M. G. McDonald et al. MOLECULAR PHARMACOLOGY
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients
- (2009) Sheng-Wen Huang et al. Pharmacogenetics and Genomics
- CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population
- (2009) Paola Borgiani et al. PHARMACOGENOMICS
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement
- (2008) D. Wang et al. BLOOD
- Prospective Study of Warfarin Dosage Requirements Based on CYP2C9 and VKORC1 Genotypes
- (2008) M-S Wen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- VKORC1polymorphisms, haplotypes and haplotype groups on warfarin dose among African–Americans and European–Americans
- (2008) Nita A Limdi et al. PHARMACOGENOMICS
- Influence ofCYP2C9andVKORC1on warfarin dose, anticoagulation attainment and maintenance among European–Americans and African–Americans
- (2008) Nita A Limdi et al. PHARMACOGENOMICS
- Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients
- (2007) Suman Lal et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now